Phacoemulsification in Patients with Fuchs Heterochromic Iridocyclitis Rajpoot Mukesh Singh1, Chouhan Pritee2, Bhargava Rahul3,*, Chauhan Anuj4, Sharma Shiv K5 1Consultant, Laser Eye Clinic, Noida 2Resident, Mahatama Gandhi Medical College, Indore 3Director, Laser Eye Clinic, Noida 4Resident, Laser Eye Clinic, Noida 5Director Rotary Eye Hospital, Palampur *Corresponding author: Dr Rahul Bhargava, Director, Laser Eye Clinic, Noida, Email: brahul2371@gmail.com. Ph: 9999055223
Online published on 8 March, 2019. Abstract Purpose To compare the safety and efficacy of phacoemulsification to treat cataract in patients with Fuchs heterochromic iridocyclitis (FHI). Method A Retrospective, multicenter study was done. Patients with cataract after FHI who had phacoemulsification were evaluated retrospectively. Complications (intraoperatively and postoperatively), operative time, visual acuities, and surgically induced astigmatism were evaluated. Results The mean follow-up period was 10.46 ± 2.56 months. The types of cataract included posterior sub-capsular cataract in 45 (86.5%) eyes and milky cataract white in 7 (13.4%) eyes. The mean preoperative vision was 0.8 ± 0.24. The mean day 1 post-operative vision was 0.28 ± 0.26 (Figure1). The mean final vision was 0.24 ± 0.10 (P <0.001). The BCVA remained less than 6/60 due to recurrent uveitis, glaucoma, vitreous opacities, healed posterior KP's and CME. However, pre-operative vitreous opacities (P =0.001) and posterior KP's (P = 0.006) had a significant effect on the final visual outcome. Conclusions Patients with a history of FHI and cataract having phacoemulsification with PC IOL implantation had excellent visual results with a relatively low complication rate. Top Keywords Phacoemulsification, Fuchs Heterochromic iridocyclitis, Cataract. Top |